CD86 and neoplasm: Therefore, the researchers genetically modified L1210 expressing CD80 and CD86, and the exosomes from the new L1210 facilitated CD4+T cell proliferation and Th1 cytokine production, resulting in significant tumor inhibition and prolonged survival time in the examined mouse model.[190] Cytokines and immune checkpoints are also key factors boosting T cell regulation.